Arecor Therapeutics PLC (AIM:AREC) won patent protection for a high-concentration version of the world’s top-selling drug.
It perfected the technically tricky feat of producing the new iteration of Humira, also known as adalimumab, using its Arestat technology.
Netscientific PLC said it is encouraged by the progress being made at PDS Biotech after the US portfolio company released second-quarter results yesterday.
Ilian Iliev, NetScientific’s CEO, said: "We are pleased with the continued progress by PDS Biotech in its Phase 2 trials and broader corporate development, coming despite the ongoing volatility in the biotech public markets. We look forward to further results from its clinical development programme."
Supply@ME Capital PLC (LSE:SYME) said it now has now received a binding commitment to execute its inaugural IM (inventory monetisation) transaction from the client company concerned. Further updates regarding this transaction and its Captive Inventory Monetisation initiatives will be released in due course, the group added.
Brickability Group PLC (AIM:BRCK) has appointed Sharon Collins as an Independent non-executive with effect from 6 September 2022. Collins has more than 20 year's experience predominantly in marketing, international sales and business development roles within the healthcare sector and in 2010 co-founded Venture Life Group, which was subsequently floated on AIM, and is currently its chief commercial officer.
Union Jack Oil PLC (AIM:UJO) said an initial court hearing for its capital reduction plan to clear the way to pay a dividend has been scheduled for 12 August 2022 with the final hearing set for 30 August 2022. The timing and approval of the capital reduction remain at the discretion of the court said the UK-focused oil and gas group.
Metal Tiger PLC (AIM:MTR, OTC:MRTTF, ASX:MTR) said that associate Cobre has expanded its exploration programme at both the Ngami copper project and Kitlanya West. The aim is to unlock a new copper deposit, the junior said in a statement.